TITLE

Recently Approved

PUB. DATE
October 2006
SOURCE
Pharmaceutical Representative;Oct2006, Vol. 36 Issue 10, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents several drugs that are recently approved by the U.S. Food and Drug Administration (FDA). Actonel is already confirmed to increase bone mass in men with osteoporosis. GlaxoSmithKline's Avandamet has been approved by the FDA for use with diet and exercise as an initial treatment for type 2 diabetes. Takeda Pharmaceuticals North America Inc.'s combination drug Duetact was approved as an adjunct to diet and exercise to improve glycemic control in type 2 diabetes.
ACCESSION #
23222429

 

Related Articles

  • New Labeling For Takeda's Edarbi Given Green Light.  // Chain Drug Review;5/23/2011, Vol. 33 Issue 9, p75 

    The article reports on the approval by the Food and Drug Administration to Takeda Pharmaceuticals North America Inc.'s drug Edarbi in the U.S.

  • IDI News Round-up.  // PharmaWatch: Monthly Review;Jul2007, Vol. 6 Issue 7, p20 

    The article offers news briefs related to developments in treating immune disorders and inflammation in the U.S. Takeda Pharmaceuticals North America Inc. revealed that it is revising warnings related to congestive heart failure in the prescribing label of Actos after the Food and Drug...

  • FDA reviewing preliminary safety information on Actos (pioglitazone).  // Biomedical Market Newsletter;12/20/2010, p93 

    The article reports that the U.S. Food & Drug Administration has announced that it has begun a safety review of the diabetes drug Actos manufactured by Takeda Pharmaceuticals North America Inc. The review follows preliminary results from a long-term observational study designed to evaluate the...

  • Ramelteon approved as nonbenzodiazepine option for insomnia. Lamb, Ed // Pharmacy Today;Aug2005, Vol. 11 Issue 8, p11 

    Reports on the release of the Ramelteon, an insomnia drug from Takeda Pharmaceuticals North America Inc. in the U.S. Approval from the Food and Drug Administration; Identification of the drug as a melatonin receptor agonist; Presentation of the clinical trial. INSET: At a glance....

  • Novel sleep medication approved for long-term use.  // Drug Topics;8/8/2005, Vol. 149 Issue 15, p4 

    Reports that the U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Inc.'s Rozerem tablets for the treatment of insomnia.

  • Pioglitazone may increase fracture risk in women.  // Reactions Weekly;3/17/2007, Issue 1143, p2 

    The article reports on the issuance by Takeda Pharmaceuticals North America Inc. of a Dear Health Care Professional letter concerning the use of pioglitazone-containing products in the treatment of women with type 2 diabetes mellitus which may be associated with an increased fracture rate. The...

  • Long-term pioglitazone use may increase bladder cancer risk. Coleman, Craig I. // Drug Topics;Aug2011, Vol. 155 Issue 8, p20 

    The article reports on the online safety communication published by the U.S. Food and Drug Administration (FDA) which addresses the health risks of using ploglitzone (Actos). It states that long-term use of pioglitazone from Takeda Pharmaceuticals North America Inc. increases the risk of bladder...

  • Approvals and Filings.  // Applied Clinical Trials;Sep2005, Vol. 14 Issue 9, p20 

    Reports on drug approvals and filings with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), as of September 2005. Takeda Pharmaceuticals North America Inc.'s receipt of FDA approval for its Rozerem 8-mg prescription sleep medication; Receipt by the EMA of a...

  • News Briefs.  // American Journal of Health-System Pharmacy;4/15/2010, Vol. 67 Issue 8, p597 

    The article offers news briefs on the pharmaceutical industry. U.S. Food and Drug Administration (FDA) and Takeda Pharmaceuticals North America Inc. have announced that dexlansoprazole will now be available under brand name of Dexilant instead of Kapidex. A new drug delivery system for...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics